PATENT CLAIM ANALYSIS

Application Number: 16064242
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["544", "106000"]

Abstract:
The present invention relates to the crystal form of imidazolone type compounds, and a preparation method, pharmaceutical composition and use thereof, and falls within the field of pharmaceutical compound crystals. The crystal form provided by the present invention has a good stability, comprising good stability under the three extreme conditions of high temperature, high humidity and strong illumination, and can also maintain a good stability during the tablet compressing process. The crystal form provided by the present invention has good absorption and metabolism properties in vivo, comprising the drug concentration of blood, the drug concentration-time curve AUC, the half-life period, etc. In addition, the dissolving rate of the crystal form of the present invention is improved, wherein same is beneficial for the applications thereof in preparations.

Claim (Index 11):
A pharmaceutical composition comprising the crystal according to  claim 1 .

Metadata:
- Claim Count in Document: 7.0
- Percentile: 94.0
- Lexical Diversity: 1.89333
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16065880', '15820241', '15186415', '16065884', '16318055']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7786718849994793
- 35 USC 102 Novelty (BERT): 0.4980689114063123
- Combined Prediction Score: 0.7506115876401626
- Mean Citation Score: 283.1884639999999
- Max Citation Score: 293.41843
- Similarity Product: 257.8173180979234

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test